{
  "pmcid": "2728117",
  "sha256": "77a3a1c41865bc5fac395568576887f55f5ce305d002e36373819878d8176f7a",
  "timestamp_utc": "2025-11-09T23:45:59.828207+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.187592592592598,
    "reading_ease": 24.559166666666698,
    "word_count": 270
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Low-Dose Intravenous Lidocaine for Postoperative Analgesia in Total Hip Arthroplasty"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised, double-blinded trial included 60 patients undergoing total hip arthroplasty."
      },
      "Participants": {
        "score": 2,
        "evidence": "60 patients undergoing total hip arthroplasty"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to receive either lidocaine 1% (lido group) with a 1.5 mg/kg IV bolus followed by a 1.5 mg/kg/h IV infusion or saline (control group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate whether a continuous intravenous (IV) low-dose lidocaine infusion reduced postoperative pain and modified nociceptive pain threshold after total hip arthroplasty."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was postoperative analgesia, measured by morphine consumption over 48 hours."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both patients and clinicians were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Sixty patients were randomised, 30 to each group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "all were analysed using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Lidocaine did not induce any opioid-sparing effect during the first 24 hours (−2 mg, 95% CI [−5; 9]; p = 0.55)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}